Jingliang Jiao

Title: Innovations of Jingliang Jiao in Pharmaceutical Chemistry.

Introduction

Jingliang Jiao is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target macrophage migration inhibitory factor (MIF). His work has implications for treating various pathological conditions, including microbial infections and tumor growth.

Latest Patents

Jingliang Jiao holds a patent for "Isoindolin-1-ones as macrophage migration inhibitory factor (MIF) inhibitors." This patent describes compounds with an isoindolin-1-one backbone that are useful in treating and preventing microbial infections, tumor growth, metastasis, and other MIF-modulated conditions. The patent also includes pharmaceutical compositions and methods for using these compounds.

Career Highlights

Jingliang Jiao is associated with Controlled Chemicals, Inc., where he continues to innovate in the field of pharmaceuticals. His expertise in developing MIF inhibitors showcases his commitment to advancing medical science and improving therapeutic options.

Collaborations

Jingliang collaborates with Jules A. Shafer, contributing to the research and development efforts at Controlled Chemicals, Inc. Their partnership enhances the potential for groundbreaking discoveries in pharmaceutical applications.

Conclusion

Jingliang Jiao's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. His contributions are paving the way for new treatments that could significantly impact patient care.